Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1493 (LINC01493) is a member of the long intergenic non-coding RNA (lincRNA) family, which are autonomous RNA transcripts longer than 200 nucleotides and do not overlap with protein-coding genes[1][3]. LINC01493 itself is not a protein-coding gene and does not encode a known receptor, enzyme, transporter, or other conventional drug target[1][3]. LincRNAs as a class contribute to the regulation of gene expression, often through chromatin remodeling, transcriptional regulation, and other sequence-dependent or sequence-independent mechanisms[3]. Although some lincRNAs have been linked to cell-type-specific functions or disease associations, there is no evidence in current resources that LINC01493 specifically serves as a therapeutic target, biomarker, or has known drug interactions or disease roles[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1493 (LINC01493).